1-3 of 3
Francesca Gesullo, MSc
Close
Sort by
Journal Articles

Revised DIPSS-Plus: A Composite Clinical, Cytogenetic and Molecular Prognostic System for Primary Myelofibrosis

Ayalew Tefferi, MD, Paola Guglielmelli, MD PhD, Terra L. Lasho, PhD, Francesca Gesullo, MSc, Christy Finke, BS, Francesco Mannelli, Animesh Pardanani, MBBS, PhD, Curtis A. Hanson, MD, Rhett P. Ketterling, MD, Naseema Gangat, MBBS, Alessandro M. Vannucchi
Journal: Blood
Blood (2017) 130 (Supplement 1): 4192.
https://doi.org/10.1182/blood.V130.Suppl_1.4192.4192
Published: 2017
Journal Articles

Changing Patterns, and Clinical Correlates, of Mutations in Patients with Myelofibrosis over Treatment with Ruxolitinib or Hydroxyurea

Alessandro M. Vannucchi, Annalisa Pacilli, PhD, Giada Rotunno, MSc, PhD, Francesco Mannelli, Chiara Paoli, BiSci, Carmela Mannarelli, MSc, PhD, Annalisa Franci, RN, Tiziana Fanelli, BiSc, Alessandro Pancrazzi, PhD, Francesca Gesullo, MSc, Giuditta Corbizi Fattori, BiSc, Alberto Bosi, MD, Paola Guglielmelli, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4195.
https://doi.org/10.1182/blood.V130.Suppl_1.4195.4195
Published: 2017
Journal Articles

Prognotic Impact of Mutations in Systemic Mastocytosis

Lisa Pieri, MD PhD, Giada Rotunno, MSc, PhD, Francesca Gesullo, MSc, Tiziana Fanelli, MSc, Giuditta Corbizi Fattori, MSc, Annalisa Pacilli, PhD, Federica Scarfì, MD, Maria Loredana Iorno, MD, Fabio Almerigogna, MD, Roberto Salerno, MD, Paola Guglielmelli, MD PhD, Roberta Zanotti, MD, Alessandro M. Vannucchi, MD
Journal: Blood
Blood (2016) 128 (22): 1953.
https://doi.org/10.1182/blood.V128.22.1953.1953
Published: 2016